Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02970123 · ClinicalTrials.gov registry record · NA

Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)

A NA study of Chronic Kidney Disease, sponsored by Srinvasan Beddhu.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT02970123 is a NA study of Chronic Kidney Disease that has completed, run by Srinvasan Beddhu. The registered enrollment target is 106 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02970123, a NA study of Chronic Kidney Disease, has completed, sponsored by Srinvasan Beddhu.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

Sedentary behavior is engaging in activities in the seated or lying position that barely raise the energy expenditure level and has emerged as an important risk factor for obesity, diabetes, cardiovascular disease and mortality. The primary hypothesis is that the Sit Less, Interact, Move More (SLIMM) intervention in Chronic Kidney Disease (CKD) will be effective in decreasing sedentary duration by increasing casual walking duration and thereby, increase physical activity energy expenditure.

Conditions Studied

Interventions

  • BEHAVIORAL Sit Less, Interact, Move More (SLIMM)

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2016-12
Est. Completion 2019-09-12
Phase NA

Sponsor

Srinvasan Beddhu

3 total trials

What the Registry Record Tells You About NCT02970123

The ClinicalTrials.gov registry entry for NCT02970123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower). The listed sponsor is Srinvasan Beddhu, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Sit Less, Interact, Move More (SLIMM) is the first listed.

NCT02970123 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT02970123 about?

NCT02970123 is a clinical study titled "Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in Chronic Kidney Disease (CKD)". Sedentary behavior is engaging in activities in the seated or lying position that barely raise the energy expenditure level and has emerged as an important risk factor for obesity, diabetes, cardiovascular disease and mortality. The primary hypothesis is that the Sit Less, Interact, Move More (SLIM...

What is the current status of trial NCT02970123?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2016-12. Estimated completion is 2019-09-12.

What conditions does trial NCT02970123 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT02970123?

The interventions under investigation include: Sit Less, Interact, Move More (SLIMM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02970123?

This trial is sponsored by Srinvasan Beddhu, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02970123 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.